TrialBMC infectious diseases2021

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.

Nurullah Okumuş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.